Imipenem/Cilastatin is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please sign in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Bacterial endocarditis (caused by MSSA)
- Septicemia
- Skin/soft tissue infections (not MRSA)
- Lower respiratory tract infections (e.g., nosocomial pneumonia)
- Gynecologic infections
- Intra-abdominal infections
- Polymicrobial infections
- Uncomplicated and complicated urinary tract infections (pyelonephritis)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Gas gangrene
- Diabetic foot infection
- Bone/joint infections
-- To view the remaining sections of this topic, please sign in or purchase a subscription --
Last updated: August 2, 2015
Citation
* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Imipenem/Cilastatin
ID - 540281
A1 - Bartlett,John,M.D.
AU - Pham,Paul,Pharm.D.
Y1 - 2015/08/02/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540281/all/Imipenem_Cilastatin
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -